Long noncoding RNA MRAK009713 is a novel regulator of neuropathic pain in rats
Authors:
- 11 July 2017
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 158 (10) , 2042-2052
Abstract
Long noncoding RNAs have been implicated in neuropathy. Here, we identify and validate a long noncoding RNA, MRAK009713, as the primary regulator of neuropathic pain in chronic constriction injury (CCI) rats. MRAK009713 expression was markedly increased in CCI rats associated with enhanced pain behaviors, and small interfering RNA against MRAK009713 significantly reduced both mechanical and thermal hyperalgesia in the CCI rats. MRAK009713 is predicted to interact with the nociceptive P2X3 receptor by CatRAPID, a bioinformatics technology. Overexpression of MRAK009713 markedly increased expression of P2X3 in the dorsal root ganglia of the control rats, and MRAK009713 small interfering RNA significantly inhibited the P2X3 expression in the dorsal root ganglia of the CCI rats. MRAK009713 directly interacted with the P2X3 protein heterologously expressed in the human embryonic kidney (HEK) 293 cells and potentiated P2X3 receptor function. Thus, MRAK009713 is a novel positive regulator of neuropathic pain in rats through regulating the expression and function of the P2X3 receptor.Keywords
This publication has 40 references indexed in Scilit:
- Regulation of Transcription by Long Noncoding RNAsAnnual Review of Genetics, 2014
- Noncoding RNAs: key molecules in understanding and treating painTrends in Molecular Medicine, 2014
- Purinergic signalling: from discovery to current developmentsExperimental Physiology, 2014
- Long Noncoding RNAs: Cellular Address Codes in Development and DiseaseCell, 2013
- Predicting protein associations with long noncoding RNAsNature Methods, 2011
- Purinergic Receptors and PainCurrent Pharmaceutical Design, 2009
- Purinergic signalling and disorders of the central nervous systemNature Reviews Drug Discovery, 2008
- Physiology and Pathophysiology of Purinergic NeurotransmissionPhysiological Reviews, 2007
- Mechanisms of Neuropathic PainNeuron, 2006
- Purinergic P2 receptors as targets for novel analgesicsPharmacology & Therapeutics, 2006